Motley Fool – Earnings Transcripts
Full earnings call transcripts from The Motley Fool
Heritage Commerce Corp (HTBK) Q4 2025 Earnings Call Transcript
Heritage Commerce Corp reported a strong deposit surge of $160.7 million in Q4 2025, with 95% of the growth coming from non‑maturity accounts, while loan balances slipped $37 million due to higher payoffs. Net interest margin rose to 3.44% as funding costs fell, even though loan‑portfolio yield dipped slightly after the Fed’s rate cuts. Credit quality remained solid, with non‑accrual loans at 0.09% of total and the tangible common equity ratio climbing to 9.3%. Management reaffirmed guidance for 5‑8% annualized loan growth and highlighted a $460 million commercial loan pipeline.
Septerna Inc (SEPN) Q4 2025 Earnings Call Transcript
Sequans Communications reported Q4 2025 revenue of $7 million, a 72.6% sequential increase driven primarily by product shipments. Gross margin was 37.7% (about 43% excluding inventory provisions) and operating expenses fell to $11.5 million. The company ended the quarter with $68 million in...
Arq Inc (ARQ) Q4 2025 Earnings Call Transcript
Arcutis Biotherapeutics reported record Q4 2025 results, with net product revenue of $127.5 million, an 84% year‑over‑year increase, and full‑year revenue up 123% to $372.1 million. Management raised its 2026 net product revenue guidance to $480‑$495 million, citing strong prescription growth, expanded Medicare...
Boundless Bio Inc (BOLD) Q4 2025 Earnings Call Transcript
Biodesix reported fiscal 2025 revenue of $88.5 million, a 4,124 % year‑over‑year increase driven largely by its lung‑diagnostics business. Gross margins rose to 83 % in Q4 and the company posted its first positive adjusted EBITDA of $530 k. A strengthened balance sheet now...
Coherus Oncology Inc (CHRS) Q4 2025 Earnings Call Transcript
Coherus Oncology (CHRS) reported several milestones in its Q4 2025 earnings call, highlighted by Merck exercising its option on the AI‑discovered infectious‑disease candidate EVX‑B3, marking the first in‑licensing of an AI‑identified vaccine. The company’s personalized melanoma vaccine EVX‑01 delivered a...
Zevra Therapeutics Inc (ZVRA) Q4 2025 Earnings Call Transcript
Zevra Therapeutics reported Q3 2025 net revenue of $26.1 million, driven primarily by $22.4 million from its FDA‑approved NPC therapy MyPlayFa. The company narrowed its net loss to $0.5 million, a dramatic improvement from a $33.2 million loss a year earlier, while cash and...
Voyager Technologies Inc (VOYG) Q4 2025 Earnings Call Transcript
Global Business Travel Group (GBTG) posted a strong Q4 2025, reporting $10 billion total transaction value—a 45% jump—and $792 million revenue, up 34% year‑over‑year. Adjusted EBITDA rose 17% to $130 million, while free cash flow reached $104 million for the full year. AI‑driven digital...
Anixa Biosciences Inc (ANIX) Q1 2026 Earnings Call Transcript
Anixa Biosciences reported $131.7 million in cash, no debt, and a cash burn of $7.1 million in Q1 2026, extending its runway to over three years. Operating expenses fell sharply, with R&D down 55% YoY and G&A reduced by 32%, reflecting the end...
Franklin Street Properties Corp (FSP) Q4 2025 Earnings Call Transcript
Franklin Street Properties Corp announced Michael Comparato as CEO and Brian Buffone as President, signaling a leadership overhaul as the firm pivots toward a diversified commercial‑real‑estate platform. The board reduced the quarterly dividend to $0.20 per share to preserve book...
MacroGenics Inc (MGNX) Q4 2025 Earnings Call Transcript
MacroGenics reported 2024 revenue of $150 million, up from $58.7 million, largely fueled by $85 million in milestone payments from its Incyte partnership. The company posted a net loss of $67 million versus $9.1 million a year earlier, while cash and marketable securities fell to...
RideNow Group Inc (RDNW) Q4 2025 Earnings Call Transcript
Radian Group reported a strong fourth‑quarter 2025, posting $159 million net income from continuing operations and a full‑year net income of $618 million, driven by an 8% share‑count reduction and robust mortgage‑insurance growth. The company completed its $1.67 billion acquisition of Inigo, a...
Dianthus Therapeutics Inc (DNTH) Q4 2025 Earnings Call Transcript
ADT Inc. posted full‑year 2025 revenue of $5.1 billion, a 5% increase, and adjusted EBITDA of $2.68 billion, up 4%. Adjusted EPS rose 19% to $0.89 per share, while free cash flow grew 16% and the company returned nearly $800 million to shareholders....
SAB Biotherapeutics Inc (SABS) Q4 2025 Earnings Call Transcript
Altimmune reported a full‑year net loss of $27.4 million but boosted its cash balance to roughly $340 million, extending its runway through 2028. The company secured FDA Breakthrough Therapy designation for its dual GLP‑1/glucagon agonist PEMB and confirmed alignment on the pivotal...
Vail Resorts Inc (MTN) Q2 2026 Earnings Call Transcript
Vail Resorts reported a 4% year‑over‑year increase in resort net revenue, driven by strong Australian visitation and the new Epic Australia four‑day pass. Reported EBITDA remained flat as weather‑related gains and efficiency savings were offset by inflation, higher marketing spend,...
Mammoth Energy Services Inc (TUSK) Q4 2025 Earnings Call Transcript
Mammoth Energy Services reported $16.4 million revenue in Q2 2025 but posted a $35.7 million GAAP net loss, driven largely by a $31.7 million non‑cash impairment on its Northern White Sand mine. The quarter featured three major portfolio moves: a $108.7 million sale of infrastructure...
Clarus Corp (CLAR) Q4 2025 Earnings Call Transcript
Core Laboratories reported Q4 2025 revenue of $138.3 million, up 3% sequentially and 7% year‑over‑year, driven by stronger international demand for reservoir rock and fluid analysis. The Reservoir Description segment posted a 14% operating margin, expanding 60 basis points, while Production...
Grove Collaborative Holdings Inc (GROV) Q4 2025 Earnings Call Transcript
Grove Collaborative reported Q3 2025 revenue of $43.7 million, a 9.4% year‑over‑year decline—the smallest drop since 2021, while active customers fell 7% to 660,000 and orders slipped 12.5%. Adjusted EBITDA was a negative $1.2 million, but management expects a positive...
Quanex Building Products Corp (NX) Q1 2026 Earnings Call Transcript
Figma reported $250 million revenue for fiscal Q2 2025, a 41% year‑over‑year increase and a new quarterly record. The company posted a 129% non‑GAAP net dollar retention rate, 90% gross margin, and a 5% operating margin, while noting near‑term margin compression from...
Allient Inc (ALNT) Q4 2025 Earnings Call Transcript
Alight Inc. reported FY 2025 revenue of $2.3 billion, a 5% decline, with recurring revenue down 2.2% and project revenue falling 22%. Adjusted EBITDA slipped to $561 million (24.8% margin) and adjusted EPS to $0.50, while a $83 million goodwill impairment and higher...
Olaplex Holdings Inc (OLPX) Q4 2025 Earnings Call Transcript
Olaplex reported Q4 2025 net sales of $114.6 million, a 3.8% year‑over‑year decline, while adjusted EBITDA rose to $30.8 million, delivering a 26.9% margin. The professional channel grew 5.3% and the new hair‑mask launch generated mid‑teens sell‑through lifts, offsetting weakness in specialty...
Kura Oncology Inc (KURA) Q4 2025 Earnings Call Transcript
Syndax Pharmaceuticals reported $172 million total revenue for 2025, driven by $125 million from its menin inhibitor RevuForge and $152 million from chronic GVHD therapy Nictimvo. RevuForge saw 38% quarter‑over‑quarter revenue growth and a 35% rise in prescriptions, bolstered by an expanded NPM1...
Tuniu Corp (TOUR) Q4 2025 Earnings Call Transcript
Tuniu Corp reported a 20% year‑over‑year rise in Q4 net revenue to RMB123.5 million, driven by a 35% surge in packaged tour sales which now represent 83% of quarterly revenue. The company posted a modest RMB1.5 million GAAP net profit and RMB3.5 million...
AudioEye Inc (AEYE) Q4 2025 Earnings Call Transcript
AudioEye reported record Q2 2025 revenue of $9.9 million, a 16% year‑over‑year increase and the 38th consecutive quarter of growth. Annual recurring revenue rose to $38.2 million, up $4.9 million from a year ago, while adjusted EBITDA reached $1.9 million, a 31% gain. The...
Marvell Technology Inc (MRVL) Q4 2026 Earnings Call Transcript
Marvell Technology reported record fourth‑quarter revenue of $1.817 billion, a 27% year‑over‑year increase, driven primarily by an 88% surge in data‑center sales. The company achieved GAAP profitability and posted non‑GAAP earnings per share of $0.60, a 40% sequential rise, underscoring strong...
John Wiley & Sons Inc (WLY) Q3 2026 Earnings Call Transcript
John Wiley & Sons reported FY2025 adjusted revenue up 3% as research, academic and AI licensing drove growth, offsetting weakness in professional channels. AI licensing contributed $40 million, highlighted by an $18 million Q4 agreement, while free cash flow rose 10% to...
Orion Properties Inc (ONL) Q4 2025 Earnings Call Transcript
Orion Group Holdings reported $852 million revenue for 2025, a year‑over‑year increase, with operating income of $15 million and adjusted EBITDA of $45 million, translating to $0.25 adjusted EPS. The Marine segment delivered $545 million revenue and doubled its adjusted EBITDA margin to 10%,...
Pyxis Tankers Inc (PXS) Q4 2025 Earnings Call Transcript
Pyxis Tankers (trading as BW LPG) posted Q4 2025 results that exceeded expectations, reporting TCE income of $50,300 per available day and EPS of $0.69. The company declared a $0.57 per share dividend covering 100% of shipping NPAT and highlighted...
Information Services Group Inc (III) Q4 2025 Earnings Call Transcript
Distribution Solutions Group reported 9.8% revenue growth to $1.98 billion in 2025, driven partly by $121.5 million from recent acquisitions. Adjusted EBITDA fell to $175 million, an 8.9% margin, reflecting mix shifts, higher employee costs and one‑off items. Gexpro Services posted near‑$500 million in...
Owlet Inc (OWLT) Q4 2025 Earnings Call Transcript
Owlet reported record Q3 2025 revenue of $32 million, a 44.6% year‑over‑year increase driven by the DreamSight camera launch and strong DreamSock sales. The company posted its first operating profit of $1.2 million and adjusted EBITDA of $1.6 million, marking six consecutive quarters...
Nutex Health Inc (NUTX) Q4 2025 Earnings Call Transcript
Sensus Healthcare reported Q4 2025 revenue of $4.9 million, an 84% decline from the prior year, driven by the loss of its largest customer. Gross margin fell to 38.8% as servicing costs rose, while the company posted a $3.2 million net loss....
GoPro Inc (GPRO) Q4 2025 Earnings Call Transcript
GoPro reported Q4 2024 revenue of $201 million, matching guidance, while posting a GAAP loss of $0.24 per share and a non‑GAAP loss of $0.09 per share. Subscription revenue rose 9% year‑over‑year, driven by an 8% increase in ARPU and...
Capital Clean Energy Carriers Corp (CCEC) Q4 2025 Earnings Call Transcript
Carrier Global reported Q4 2025 sales of $4.8 billion, a 9% organic decline offset by a modest foreign‑currency tailwind. Adjusted operating profit fell 33% to $455 million, reflecting weaker residential and light‑commercial volumes and an unfavorable mix. Management highlighted a surge in...
TriSalus Life Sciences Inc (TLSI) Q4 2025 Earnings Call Transcript
TriSalus Life Sciences reported Q3 2025 revenue of $11.6 million, a 57% year‑over‑year increase, while adjusted EBITDA loss narrowed to $5.4 million despite one‑time study charges. Gross margin slipped to 84% as new product launches strained manufacturing efficiency, but cash burn improved,...
Traeger Inc (COOK) Q4 2025 Earnings Call Transcript
Traeger Inc. posted full‑year 2025 revenue of $560 million, topping the high end of its guidance, and adjusted EBITDA of $70 million, landing in the upper half of the forecast range. Q4 revenue fell 14% year‑over‑year to $145 million, with grill sales down...
Carparts.Com Inc (PRTS) Q4 2025 Earnings Call Transcript
CarParts.com reported FY 2024 revenue of $589 million, a 13% decline year‑over‑year, with gross profit of $197 million and a 33.4% gross margin, near the top of guidance. The fourth‑quarter results showed revenue down 15% to $133.5 million and a GAAP net loss...
Atea Pharmaceuticals Inc (AVIR) Q4 2025 Earnings Call Transcript
Atea Pharmaceuticals reported a $329.3 million cash position that funds its Phase III hepatitis C program through 2027 and supports a new hepatitis E pipeline. The CBEYOND and C FORWARD trials are on track, with enrollment completing next month and mid‑2026 respectively, and top‑line data...
Liquidia Corp (LQDA) Q4 2025 Earnings Call Transcript
QuidelOrtho reported solid top‑line growth in Q4 2025, with its Labs segment up 7% quarter‑over‑quarter and 6% for the full year, driven by strong regional performance in LATAM and EMEA. Adjusted diluted EPS reached $0.46 in the quarter and $2.12...
Ciena Corp (CIEN) Q1 2026 Earnings Call Transcript
Ciena reported record fiscal 2025 revenue of $4.77 billion, up 20% year‑over‑year, and EPS of $2.64, a 45% increase. The company posted a $7.8 billion order backlog of roughly $5 billion and raised its fiscal 2026 revenue outlook to $5.7‑$6.1 billion, reflecting strong demand...
Kingstone Companies Inc (KINS) Q4 2025 Earnings Call Transcript
Kinsale Capital Group reported a 26% jump in diluted operating earnings per share to $5.81 in Q4 2025, while net written premiums rose 7.1% and the combined ratio improved to 71.7%. The insurer’s operating return on equity hit 26%, book value...
Aligos Therapeutics Inc (ALGS) Q4 2025 Earnings Call Transcript
Agilon Health reported FY 2025 revenue of $5.93 billion, with Q4 revenue of $1.57 billion, but both medical margin and adjusted EBITDA remained negative, driven by higher inpatient claims and market exits. The company cut operating expenses by $35 million and extended its...
Entravision Communications Corp (EVC) Q4 2025 Earnings Call Transcript
Evercore reported record 2025 results, posting $3.9 billion in adjusted net revenue, a 29% increase year‑over‑year, and a record $1.3 billion in Q4 alone. Adjusted operating income rose 50% to $839 million, while adjusted EPS jumped 55% to $14.56. Non‑M&A businesses contributed roughly...
Contineum Therapeutics Inc (CTNM) Q4 2025 Earnings Call Transcript
Compugen Ltd. reported a dramatic financial turnaround in its Q4 2025 earnings, posting a $56.8 million quarterly profit and $35.3 million annual profit after a year of losses. A $65 million upfront royalty monetization from AstraZeneca boosted cash to $145.6 million, extending the cash runway...
Cooper Companies Inc (COO) Q1 2026 Earnings Call Transcript
Cooper Companies reported record Q2 2021 results, delivering $720 million in revenue, a 37% year‑over‑year increase, driven by strong performances in both CooperVision and CooperSurgical. CooperVision posted a 25% revenue rise to $523 million, while CooperSurgical surged 58% to $197 million, supported by...
One Liberty Properties Inc (OLP) Q4 2025 Earnings Call Transcript
OpenLane Inc. reported fourth‑quarter 2025 revenue of $494 million, up 9% year‑over‑year, and adjusted EBITDA of $76 million, a 5% increase. Dealer‑to‑dealer volumes surged over 20% in Q4, while the finance segment delivered 6% EBITDA growth despite flat net yields. The company...
Myers Industries Inc (MYE) Q4 2025 Earnings Call Transcript
Paysafe Limited reported full‑year 2025 revenue of $1.7 billion, delivering 6% organic growth despite a divestiture that trimmed EBITDA. Digital Wallet revenue reached $815 million with a 42%‑plus margin and the consumer base grew to 7.8 million users. Enterprise deal volume surged 38%...
Brilliant Earth Group Inc (BRLT) Q4 2025 Earnings Call Transcript
Brightstar Lottery reported Q4 2025 revenue of $668 million, a 3% increase, and full‑year revenue of $2.51 billion, flat year‑over‑year. Adjusted EBITDA rose 5% in the quarter to $304 million but fell to $1.12 billion for the year as prior‑year incentives and UK contract...
Costco Wholesale Corp (COST) Q2 2026 Earnings Call Transcript
AutoZone reported Q2 2026 total sales of $4.3 billion, up 8.1% year‑over‑year, while EPS fell 2.3% to $27.63 after a $59 million non‑cash LIFO charge. Excluding the LIFO impact, EPS would have risen 7.1% and gross margin would have improved. Domestic same‑store...
Smith & Wesson Brands Inc (SWBI) Q3 2026 Earnings Call Transcript
Smith & Wesson Brands (SWBI) posted record Q3 2026 revenue of $233 million, up 20% year‑over‑year, largely fueled by a $650 million Mars Parts acquisition and two smaller deals totaling $26.5 million. Adjusted consolidated EBITDA reached a new quarterly high of $45 million, though...
Distribution Solutions Group Inc (DSGR) Q4 2025 Earnings Call Transcript
Distribution Solutions Group reported Q2 2025 revenue of $502 million, a 14.3% year‑over‑year increase driven by acquisitions and 3.3% organic daily‑sales growth. Adjusted EBITDA margin rose to 9.7% of sales, up from 9% in the prior quarter, with every vertical posting...
OFS Credit Company Inc (OCCI) Q1 2026 Earnings Call Transcript
OFS Credit Company reported first‑quarter 2026 revenue of $381 million, a modest 1% increase, while new‑boat sales fell 6% and pre‑owned sales surged 24%. Gross profit rose to $89 million, lifting the margin 110 basis points to 23.5%. The company posted a...